Education
About Us
Working with TipRanks
Follow Us
Renascience Inc. (JP:4889)
:4889
Total Valuation
Renascience Inc. has a market cap or net worth of ¥19.49B. The enterprise value is ―.
Market Cap¥19.49B
Enterprise Value―
Share Statistics
Renascience Inc. has 12,711,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,711,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Renascience Inc.’s return on equity (ROE) is -0.16 and return on invested capital (ROIC) is -12.95%.
Return on Equity (ROE)-0.16
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-12.95%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee48.54M
Profits Per Employee-64.09M
Employee Count4
Asset Turnover0.09
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Renascience Inc. is -18.30. Renascience Inc.’s PEG ratio is 0.70.
PE Ratio-18.30
PS Ratio0.00
PB Ratio7.02
Price to Fair Value2.94
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio0.70
Income Statement
In the last 12 months, Renascience Inc. had revenue of 194.16M and earned -258.33M in profits. Earnings per share was -20.32.
Revenue194.16M
Gross Profit165.64M
Operating Income-252.34M
Pretax Income-256.38M
Net Income-258.33M
EBITDA-250.50M
Earnings Per Share (EPS)-20.32
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Renascience Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.49
52-Week Price Change357.89%
50-Day Moving Average1.21K
200-Day Moving Average739.30
Relative Strength Index (RSI)64.16
Average Volume (3m)2.04M
Important Dates
Renascience Inc. upcoming earnings date is Aug 7, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 7, 2025
Ex-Dividend Date―
Financial Position
Renascience Inc. as a current ratio of 16.56, with Debt / Equity ratio of 0.00%
Current Ratio16.56
Quick Ratio16.56
Debt to Market Cap0.08
Net Debt to EBITDA6.67
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Renascience Inc. has paid 1.96M in taxes.
Income Tax1.96M
Effective Tax Rate>-0.01
Enterprise Valuation
Renascience Inc. EV to EBITDA ratio is -12.21, with an EV/FCF ratio of -13.18.
EV to Sales15.75
EV to EBITDA-12.21
EV to Free Cash Flow-13.18
EV to Operating Cash Flow-13.27
Balance Sheet
Renascience Inc. has ¥1.84B in cash and marketable securities with ¥0.00 in debt, giving a net cash position of -¥1.84B billion.
Cash & Marketable Securities¥1.84B
Total Debt¥0.00
Net Cash-¥1.84B
Net Cash Per Share-¥144.98
Tangible Book Value Per Share¥126.40
Margins
Gross margin is 96.21%, with operating margin of -129.96%, and net profit margin of -133.05%.
Gross Margin96.21%
Operating Margin-129.96%
Pretax Margin-132.04%
Net Profit Margin-133.05%
EBITDA Margin-129.01%
EBIT Margin-129.96%
Analyst Forecast
The average price target for Renascience Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-27.27%
EPS Growth Forecast―